Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Vagus Nerve Stimulation Devices Market by Product Type (Implantable VNS Devices and External VNS Devices) and End User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_184503

Pages: NA

Charts: NA

Tables: NA

Vagus nerve stimulation device is referred to as a pacemaker for the brain, which stimulates the vagus nerve with the help of electrical impulses. The device is located under the skin on the chest wall and electrical impulse passes through a wire to the vagus nerve in the neck. This vagus nerve controls the functions of the body, which are not controlled voluntarily (for example, the heart rate).

Rise in prevalence of neurological and cardiovascular disorders, increase in geriatric population, growth in support from government and private organizations, and introduction of favorable reimbursement policies drive the market. However, high cost of these devices and complications associated with vagus nerve stimulation restrain the market growth. Furthermore, high adoption rate of minimally invasive VNS procedures and development of next-generation therapies for neurological disorders drive the market growth during the forecast period.

The carotid artery stents market is segmented based on product type, end user, and region. Based on product type, it is bifurcated into balloon expandable stents and self-expanding stents. On the basis of material, the market is classified into implantable VNS devices and external VNS devices. On the basis of end user, the market is divided into hospitals, and ambulatory surgical centers. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include LivaNova Plc., EnteroMedics Inc., Beijing Pharmaceutical Group Co., Ltd., BioControl Medical (B.C.M) Ltd., and electroCore LLC.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global vagus nerve stimulation device market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.

Vagus Nerve Stimulation Device Market Key Segments

By Product Type

  • Implantable VNS Devices
  • External VNS Devices

By End User

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 VAGUS NERVE STIMULATION DEVICE MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BALLOON EXPANDABLE STENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SELF-EXPANDING STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 VAGUS NERVE STIMULATION DEVICE MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS

5.3.1. Market size and forecast

CHAPTER 6 VAGUS NERVE STIMULATION DEVICE MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Vagus Nerve Stimulation Device Market by Product Type
6.2.5. North America Vagus Nerve Stimulation Device Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Vagus Nerve Stimulation Device Market by Product Type
6.3.5. Europe Vagus Nerve Stimulation Device Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Vagus Nerve Stimulation Device Market by Product Type
6.4.5. Asia-Pacific Vagus Nerve Stimulation Device Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA Vagus Nerve Stimulation Device Market by Product Type
6.5.5. LAMEA Vagus Nerve Stimulation Device Market by End User

CHAPTER 7 COMPANY PROFILES

7.1. LIVANOVA PLC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ENTEROMEDICS INC.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. BEIJING PHARMACEUTICAL GROUP CO., LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. BIOCONTROL MEDICAL (B.C.M) LTD.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ELECTROCORE LLC

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

Purchase Full Report of
Vagus Nerve Stimulation Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 60% discount on subscription plans on


KNOWLEDGETREE